Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAALL F01
2015-002734-41Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2015
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2015; status: active.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2015-002734-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002734-41.